Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Dr Thomas Lung, of The George Institute, explains how young people will be the hardest hit when it comes experiencing a loss in life expectancy by being overweight or obese.